Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$85.37 - $115.44 $208,815 - $282,366
-2,446 Reduced 99.96%
1 $0
Q4 2023

Feb 12, 2024

BUY
$69.51 - $104.43 $169,812 - $255,122
2,443 Added 61075.0%
2,447 $243,000
Q3 2023

Nov 02, 2023

BUY
$96.41 - $126.61 $289 - $379
3 Added 300.0%
4 $0
Q1 2023

May 03, 2023

SELL
$135.66 - $197.02 $2,984 - $4,334
-22 Reduced 95.65%
1 $0
Q4 2022

Feb 03, 2023

BUY
$118.38 - $210.04 $2,722 - $4,830
23 New
23 $4,000
Q2 2022

Jul 18, 2022

BUY
$117.13 - $176.59 $585 - $882
5 New
5 $1,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Tfo Tdc, LLC Portfolio

Follow Tfo Tdc, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfo Tdc, LLC with notifications on news.